脊柱关节炎患者的肠道菌群变化:一项系统综述
该系统综述检索截至2021年6月1日的多个数据库,纳入23篇文章中的28项研究,比较脊柱关节炎(SpA)患者与健康对照的肠道菌群。β多样性显示SpA患者微生物组成显著不同;多个菌属水平差异在≥3项研究中一致,如强直性脊柱炎患者放线菌门、戴阿利斯特菌属、链球菌属和Clostridium bolteae增多,拟杆菌目和副萨特菌属减少。
要点
- SpA患者与对照的肠道菌群β多样性存在显著差异。
- 强直性脊柱炎患者放线菌门、戴阿利斯特菌属、链球菌属和Clostridium bolteae增多,拟杆菌目和副萨特菌属减少(≥3项研究)。
- 所有SpA研究中变形菌门、肠杆菌科和拟杆菌科增多,拟杆菌门、拟杆菌目和Akkermansia减少(≥3项研究)。
核心结论
- 该系统综述总结的SpA微生物特征为基于证据的微生物治疗奠定了基础。
- SpA各亚型间的微生物差异仍有待探索。
- 需要进一步研究以阐明改变的微生物群如何参与SpA的发病机制。
研究设计与样本
- 系统综述,检索MEDLINE、EMBASE、Cochrane系统综述数据库和Cochrane对照试验中心注册库,截至2021年6月1日,纳入比较SpA患者与健康对照肠道菌群的研究。
- 从3756条记录中纳入23篇文章的28项研究进行分析。
主要发现
- β多样性结果显示SpA患者与对照的微生物组成显著不同。
- 仅纳入强直性脊柱炎(AS)患者的14项研究报告,在≥3项研究中AS病例较对照放线菌门、戴阿利斯特菌属、链球菌属和Clostridium bolteae增多,拟杆菌目和副萨特菌属减少。
- 3项研究报告轴性SpA病例较对照Dialister invisus增多。
- 2项研究报告附着点炎相关关节炎(ERA)病例较对照Bacteroides fragilis增多。
- 所有SpA研究中,≥3项研究报告病例较对照变形菌门、肠杆菌科和拟杆菌科增多,拟杆菌门、拟杆菌目和Akkermansia减少。
关键数值与推荐
- 超过40%的研究报告病例与对照在性别和年龄方面具有可比数据。
临床怎么用
- 原文未据此给出推荐。
局限性
- SpA各亚型间的微生物差异仍有待探索。
- 需要进一步研究以阐明改变的微生物群如何参与SpA的发病机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Gut microbiota has been proposed as a pivotal role in the progression of Spondyloarthritis (SpA), however diverse results remain to be synthesized. We performed a systematic review to collect evidence on the characteristic of the gut microbiota in patients with SpA, as compared to controls. METHODS: We systematically searched MEDLINE, EMBASE, Cochrane Database of Systematic Reviews, and Cochrane Central Register of Controlled Trials databases, through June 1, 2021 for studies that compared gut microbiota of cases with SpA versus healthy controls. RESULTS: Of 3756 records identified, 28 studies from 23 articles were included in the analysis. Results of β-diversity showed SpA patients hold a significantly different microbial composition compared with controls. Several taxa-level differences of gut microbiota between SpA (and its subtypes) cases and controls were identified. Fourteen studies including only patients with ankylosing spondylitis (AS) reported increased amounts of Actinobacteria, Dialister, Streptococcus, and Clostridium bolteae, and decreased amounts of Bacteroidales and Parasutterella in AS cases versus controls in ≥ 3 studies. Dialister invisus was increased in axial-SpA cases versus controls in 3 studies. Bacteroides fragilis was increased in enthesitis-related arthritis (ERA) cases versus controls in 2 studies. For all SpA studies, Proteobacteria, Enterobacteriaceae, and Bacteroidaceae were increased, whereas Bacteroidetes, Bacteroidales, and Akkermansia were decreased in cases versus controls in ≥ 3 studies. Over 40% of the studies showed comparable data of both sex and age between cases and controls. CONCLUSION: The microbial characteristics of SpA summarized in the systematic review laid the groundwork for evidence-based microbial treatment. The microbial variance among subtypes of SpA remains to be explored. Further studies are needed to elucidate how the altered microbiota participate in the pathogenesis of SpA.
引用
- Wang L, Wang Y, Zhang P, et al. Gut microbiota changes in patients with spondyloarthritis: A systematic review. Semin Arthritis Rheum. 2021. PMID: 34844732. doi:10.1016/j.semarthrit.2021.11.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。